Skip to content
healthcare.dev

LEMTRADA

NDC 58468-0200, ALEMTUZUMAB, injection, solution, concentrate, from Genzyme Corporation.

Product NDC
58468-0200
Status
Listed
Labeler
Genzyme Corporation
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103948
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALEMTUZUMAB12 mg/1.2mL

Pharmacologic classes

CD52-directed Antibody Interactions [MoA]; CD52-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
58468-0200-1584680200011 VIAL, SINGLE-USE in 1 CARTON (58468-0200-1) / 1.2 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6236b0bc-82e9-4447-9a78-f57d94770269
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=58468-0200

Use it

Look up 58468-0200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.